Comment on CMS-2026-1255-0001

Academy of Managed Care Pharmacy (AMCP)SupportAdvocacy
Summary: The Academy of Managed Care Pharmacy (AMCP) supports the proposed rule to modernize prior authorization through interoperability and standardized reporting, viewing it as a step toward improved efficiency and patient safety. However, they urge CMS to provide a longer 24-month implementation timeline, allow for stratified reporting metrics, and offer clearer guidance on state-specific Medicaid requirements to ensure operational feasibility.
The Academy of Managed Care Pharmacy (AMCP) thanks the Centers for Medicare & Medicaid Services (CMS) for the opportunity to provide comments in response to the Interoperability Standards and Prior Authorization for Drugs Proposed Rule. Please see attached for AMCP's full comments.

View on Regulations.gov